ACHC vs. XRAY, CYTK, HALO, EXEL, BPMC, OGN, LNTH, RVMD, MASI, and BBIO
Should you be buying Acadia Healthcare stock or one of its competitors? The main competitors of Acadia Healthcare include DENTSPLY SIRONA (XRAY), Cytokinetics (CYTK), Halozyme Therapeutics (HALO), Exelixis (EXEL), Blueprint Medicines (BPMC), Organon & Co. (OGN), Lantheus (LNTH), Revolution Medicines (RVMD), Masimo (MASI), and BridgeBio Pharma (BBIO). These companies are all part of the "medical" sector.
DENTSPLY SIRONA (NASDAQ:XRAY) and Acadia Healthcare (NASDAQ:ACHC) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.
Acadia Healthcare has lower revenue, but higher earnings than DENTSPLY SIRONA. Acadia Healthcare is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.
DENTSPLY SIRONA presently has a consensus target price of $35.22, indicating a potential upside of 28.27%. Acadia Healthcare has a consensus target price of $87.56, indicating a potential upside of 37.71%. Given DENTSPLY SIRONA's stronger consensus rating and higher probable upside, analysts clearly believe Acadia Healthcare is more favorable than DENTSPLY SIRONA.
DENTSPLY SIRONA has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Acadia Healthcare has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.
Acadia Healthcare received 101 more outperform votes than DENTSPLY SIRONA when rated by MarketBeat users. Likewise, 66.71% of users gave Acadia Healthcare an outperform vote while only 61.21% of users gave DENTSPLY SIRONA an outperform vote.
95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 2.0% of Acadia Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, DENTSPLY SIRONA had 9 more articles in the media than Acadia Healthcare. MarketBeat recorded 19 mentions for DENTSPLY SIRONA and 10 mentions for Acadia Healthcare. Acadia Healthcare's average media sentiment score of 0.80 beat DENTSPLY SIRONA's score of 0.78 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.
Acadia Healthcare has a net margin of -0.38% compared to Acadia Healthcare's net margin of -2.41%. Acadia Healthcare's return on equity of 11.54% beat DENTSPLY SIRONA's return on equity.
Summary
Acadia Healthcare beats DENTSPLY SIRONA on 11 of the 18 factors compared between the two stocks.
Get Acadia Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ACHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acadia Healthcare Competitors List
Related Companies and Tools
